Nina Xue Selected Research

Zj6413

5/2016

Poly (ADP-ribose) polymerases inhibitor, Zj6413, as a potential therapeutic agent against breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nina Xue Research Topics

Disease

8	Neoplasms (Cancer) 06/2022 - 03/2014
3	Glioblastoma (Glioblastoma Multiforme) 01/2021 - 01/2017
3	Insulin Resistance 06/2017 - 08/2013
2	Psoriasis (Pustulosis Palmaris et Plantaris) 02/2020 - 04/2018
2	Pancreatic Neoplasms (Pancreatic Cancer) 09/2019 - 01/2014
2	Triple Negative Breast Neoplasms 12/2018 - 05/2016
2	Obesity 11/2017 - 08/2013
2	Hyperinsulinism (Hyperinsulinemia) 01/2014 - 08/2013
1	Adenocarcinoma 05/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Experimental Arthritis 01/2019
1	Rheumatoid Arthritis 01/2019
1	Esophageal Neoplasms (Esophageal Cancer) 01/2019
1	Esophageal Squamous Cell Carcinoma 01/2019
1	Parakeratosis 04/2018
1	Type 2 Diabetes Mellitus (MODY) 06/2017
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017
1	Albuminuria 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Breast Neoplasms (Breast Cancer) 05/2016
1	Neoplasm Metastasis (Metastasis) 05/2016
1	Autoimmune Diseases of the Nervous System 07/2014
1	Bradycardia 07/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2014
1	Chronic Disease (Chronic Diseases) 03/2014
1	Hyperlipidemias (Hyperlipidemia) 01/2014
1	Hypertriglyceridemia 08/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 08/2013
1	Abdominal Obesity 08/2013
1	Body Weight (Weight, Body) 08/2013

Drug/Important Bio-Agent (IBA)

4	Pharmaceutical PreparationsIBA 01/2021 - 01/2017
3	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 05/2016
3	Proteins (Proteins, Gene)FDA Link 09/2019 - 01/2014
3	Sphingosine-1-Phosphate ReceptorsIBA 01/2019 - 07/2014
2	ProdrugsIBA 06/2022 - 01/2018
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 05/2022 - 01/2016
2	Syl930IBA 04/2018 - 07/2014
2	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 05/2016
2	Insulin (Novolin)FDA Link 11/2017 - 08/2013
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 11/2017 - 08/2013
2	Triglycerides (Triacylglycerol)IBA 01/2014 - 08/2013
1	AntibodiesIBA 06/2022
1	Low Density Lipoprotein Receptor-Related Protein-1 (LDL-Receptor Related Protein)IBA 05/2022
1	Colchicine FDA LinkGeneric 12/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2020
1	TubulinIBA 12/2020
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 09/2019
1	cryptotanshinoneIBA 01/2019
1	Therapeutic UsesIBA 01/2019
1	Janus Kinase 2IBA 01/2019
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 12/2018
1	Antineoplastic Agents (Antineoplastics)IBA 12/2018
1	Propranolol (Inderal)FDA LinkGeneric 04/2018
1	MethyltransferasesIBA 01/2018
1	Hydroxyl RadicalIBA 01/2018
1	O-(6)-methylguanineIBA 01/2018
1	CannabinoidsIBA 11/2017
1	Glucose (Dextrose)FDA LinkGeneric 11/2017
1	Adrenergic Receptors (Adrenergic Receptor)IBA 06/2017
1	Glucagon Receptors (Glucagon Receptor)IBA 06/2017
1	PhosphoenolpyruvateIBA 06/2017
1	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 06/2017
1	caffeoylquinic acidIBA 01/2017
1	Chlorogenic AcidIBA 01/2017
1	nicousamideIBA 01/2017
1	Interleukin-4 (Interleukin 4)IBA 01/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2016
1	Zj6413IBA 05/2016
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2016
1	quinone (benzoquinone)IBA 01/2016
1	Macrocyclic LactamsIBA 01/2016
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 07/2014
1	Poly (ADP-Ribose) Polymerase-1IBA 03/2014
1	LDL CholesterolIBA 01/2014
1	BezafibrateIBA 01/2014
1	Sirtuin 1IBA 01/2014
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2014
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 08/2013
1	RimonabantIBA 08/2013
1	Sodium Glutamate (Accent)IBA 08/2013

Therapy/Procedure

3	Therapeutics 12/2020 - 04/2018
1	Immunotherapy 06/2022
1	Oral Administration 12/2020